Whether, with reference to the devastating effects that an outbreak of the African Horse Sickness (AHS) will have on the local industry, she has been informed of the shortage of supplies of the annual mandatory AHS vaccine in the Republic; if not, what is the position in this regard; if so, (a) on what date was she informed of the shortage and (b) what measures has she taken in this regard;
(2) whether Onderstepoort Biological Products (OBP) took any urgent steps in response to the shortage in supplies to ensure that it can supply effective, safe and sufficient doses of the AHS vaccine in the Republic; if not, why not; if so, (a) what are the (i) details of the urgent steps taken by the OBP and (ii) timelines in this regard and (b) by what date is it envisaged that the OBP will be in a position to supply effective, safe and sufficient doses of the AHS vaccine in the Republic;
(3) whether her department intends to conclude a public-private partnership (PPP) in the (a) production and (b) sale of the AHS vaccine in order to ensure that there is no shortage in supplies of the AHS vaccine in the future; if not, why not; if so, what (i) control measures will be put in place to ensure that all AHS vaccines produced and sold through a PPP meet the required animal health standards and (ii) are the further details in this regard;
(4) whether her department will implement a mechanism that would make it possible to drastically shorten the time frame required for newly developed and tested vaccines to be registered in emergency situations in order to allow for mass production and use in a short period of time; if not, what is the position in this regard; if so, what are the relevant details?